» Articles » PMID: 32867270

Preoperative Fasting and General Anaesthesia Alter the Plasma Proteome

Overview
Journal Cancers (Basel)
Publisher MDPI
Specialty Oncology
Date 2020 Sep 2
PMID 32867270
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Blood plasma collected at time of surgery is an excellent source of patient material for investigations into disease aetiology and for the discovery of novel biomarkers. Previous studies on limited sets of proteins and patients have indicated that pre-operative fasting and anaesthesia can affect protein levels, but this has not been investigated on a larger scale. These effects could produce erroneous results in case-control studies if samples are not carefully matched.

Methods: The proximity extension assay (PEA) was used to characterize 983 unique proteins in a total of 327 patients diagnosed with ovarian cancer and 50 age-matched healthy women. The samples were collected either at time of initial diagnosis or before surgery under general anaesthesia.

Results: 421 of the investigated proteins (42.8%) showed statistically significant differences in plasma abundance levels comparing samples collected at time of diagnosis or just before surgery under anaesthesia.

Conclusions: The abundance levels of the plasma proteome in samples collected before incision, i.e., after short-time fasting and under general anaesthesia differs greatly from levels in samples from awake patients. This emphasizes the need for careful matching of the pre-analytical conditions of samples collected from controls to cases at time of surgery in the discovery as well as clinical use of protein biomarkers.

Citing Articles

Cell-type specific methylation changes in the newborn child associated to obstetric pain relief.

Tran C, Campbell T, Johnson R, Xie L, Hultman C, van den Oord E PLoS One. 2024; 19(9):e0308644.

PMID: 39298419 PMC: 11412656. DOI: 10.1371/journal.pone.0308644.


Development of a Multiprotein Classifier for the Detection of Early Stage Ovarian Cancer.

Boylan K, Petersen A, Starr T, Pu X, Geller M, Bast Jr R Cancers (Basel). 2022; 14(13).

PMID: 35804849 PMC: 9264950. DOI: 10.3390/cancers14133077.


An Exploratory Analysis of Changes in Circulating Plasma Protein Profiles Following Image-Guided Ablation of Renal Tumours Provides Evidence for Effects on Multiple Biological Processes.

Wah T, Zhong J, Wilson M, Vasudev N, Banks R Cancers (Basel). 2021; 13(23).

PMID: 34885149 PMC: 8656737. DOI: 10.3390/cancers13236037.


Pre-Therapeutic VEGF Level in Plasma Is a Prognostic Bio-Marker in Head and Neck Squamous Cell Carcinoma (HNSCC).

Siemert J, Wald T, Kolb M, Pettinella I, Bohm U, Pirlich M Cancers (Basel). 2021; 13(15).

PMID: 34359680 PMC: 8345208. DOI: 10.3390/cancers13153781.


Plasma Proteins and Cancer.

Enroth S Cancers (Basel). 2021; 13(5).

PMID: 33802275 PMC: 7959146. DOI: 10.3390/cancers13051062.

References
1.
Enroth S, Maturi V, Berggrund M, Bosdotter Enroth S, Moustakas A, Johansson A . Systemic and specific effects of antihypertensive and lipid-lowering medication on plasma protein biomarkers for cardiovascular diseases. Sci Rep. 2018; 8(1):5531. PMC: 5882890. DOI: 10.1038/s41598-018-23860-y. View

2.
Enroth S, Berggrund M, Lycke M, Broberg J, Lundberg M, Assarsson E . High throughput proteomics identifies a high-accuracy 11 plasma protein biomarker signature for ovarian cancer. Commun Biol. 2019; 2:221. PMC: 6586828. DOI: 10.1038/s42003-019-0464-9. View

3.
Glimelius B, Melin B, Enblad G, Alafuzoff I, Beskow A, Ahlstrom H . U-CAN: a prospective longitudinal collection of biomaterials and clinical information from adult cancer patients in Sweden. Acta Oncol. 2017; 57(2):187-194. DOI: 10.1080/0284186X.2017.1337926. View

4.
Nygren J, Carlsson-Skwirut C, Brismar K, Thorell A, Ljungqvist O, Bang P . Insulin infusion increases levels of free IGF-I and IGFBP-3 proteolytic activity in patients after surgery. Am J Physiol Endocrinol Metab. 2001; 281(4):E736-41. DOI: 10.1152/ajpendo.2001.281.4.E736. View

5.
Ramachandran V, Arumugam T, Wang H, Logsdon C . Anterior gradient 2 is expressed and secreted during the development of pancreatic cancer and promotes cancer cell survival. Cancer Res. 2008; 68(19):7811-8. PMC: 4429896. DOI: 10.1158/0008-5472.CAN-08-1320. View